HCC multidisciplinary summit: Integrating surgery, systemic therapy, and novel insights
Congresso RES multidisciplinare sul carcinoma epatocellulare (HCC): chirurgia, terapia sistemica, immunoterapia e strategie di conversione. Meldola (FC), IRST IRCCS Dino Amadori, 18 settembre 2026. 3 crediti ECM, gratuito.
Provider
Proeventi SrlProeventi Srl (2773)
Crediti ECM
3
Costo
Gratuito
Durata
3 ore
Date
18 settembre 2026
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.
Razionale scientifico
The landscape of hepatocellular carcinoma is rapidly evolving. Patient population is changing, with a relative increase of cases with metabolic aetiology compared with the ones derived from chronic hepatitis. Technological evolution allows to refine treatment of localized disease, from percutaneous ablation to mini-invasive surgery. The advent of immunotherapy resulted in a breakthrough in treatment of advanced disease. Furthermore, new combinations are emerging, thanks to a better understanding of HCC biology, including the complex dynamics of tumor microenvironment. The introduction of immunotherapy even in early settings, along with its integration with transarterial treatments, discloses new opportunities, that span from an improvement in survival to the promise to increase the rate of conversion to curative approaches such as liver transplantation, with the potential to redefine the boundaries of the whole therapeutic hierarchy. As a result of this evolution, the management of HCC in gaining more and more complexity, thus the key to success in HCC treatment is multidisciplinarity, where all players, working in close collaboration, must be prone to continuously reassess and modify treatment strategy. The aim of this event is to depict an overview of HCC management, highlighting up-to-date therapeutic strategies, focusing on multidisciplinarity and treatment personalization, and keeping an eye on future directions.
Luogo
Irst Irccs “Dino Amadori”
Via Piero Maroncelli, 40, Meldola (FC)
Programma
- 10:30Registrazione dei partecipanti
- 10:50Introduzione e saluti
- 12:10–12:30Liver transplantation: limits and conversionMarco Vivarelli
- 12:30–12:50News from biology: glimpse of the futureMichele Zanoni
- 12:50–13:00Discussione
- 13:00–14:00Lunch
- 14:00–14:20Immunotherapy: present and future of first-lineTiziana Pressiani
- 14:20–14:40A matter of sequence: new trials to come?Francesco Tovoli
- 14:40–15:00Therapeutic algorithm for HCC: integrating local, systemic and novel strategiesAndrea Casadei-Gardini
- 15:00–15:10Discussione
- 15:10–15:40LECTURE: Crossing the boundaries of stages and treatments: time for a new therapeutic hierarchy?Alessandro Vitale
- 15:40–16:00Discussione e chiusura dei lavori
Responsabili del corso
PROEVENTI SRL
Provider
ID Provider: N° 2773
Città: San Severo (FG)
Tipologia: Società, Agenzie Ed Enti Privati
Stato accreditamento: Standard
Giorgio Ercolani
Responsabile scientifico
Specializzazione: Professore Associato Unibo, Bologna
Carlo Fabbri
Responsabile scientifico
Specializzazione: Responsabile Gastroenterologia Forlì Cesena
Ilario Giovanni Rapposelli
Responsabile scientifico
Specializzazione: Oncologo Presso Irccs Irst "Dino Amadori"
Domande frequenti
Questo evento è accreditato per: Biologo (Biologo); Tecnico Sanitario Laboratorio Biomedico (Iscritto Nell’Elenco Speciale Ad Esaurimento); Infermiere (Infermiere); Tecnico Sanitario Laboratorio Biomedico (Tecnico Sanitario Laboratorio Biomedico).
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.